Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences
1 other identifier
observational
50
1 country
1
Brief Summary
The purpose of this study is to prospectively evaluated the T2\* values of normal feti.A standardized scale of T2\* values for fetal and neonatal iron organ overload have yet to be reported or devised.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2010
CompletedFirst Posted
Study publicly available on registry
May 12, 2010
CompletedStudy Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedMay 12, 2010
May 1, 2010
2 years
May 9, 2010
May 11, 2010
Conditions
Keywords
Eligibility Criteria
This study will be offered to motheres undergoing fetal MRI for any indication.
You may qualify if:
- Any MRI study for fetus
You may not qualify if:
- Known iron deposition problem in the mother of fetus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheba medical center
Tel Litwinsky, Israel, 52621, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
May 9, 2010
First Posted
May 12, 2010
Study Start
June 1, 2010
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
May 12, 2010
Record last verified: 2010-05